R egulatory T cells (Tregs), a subset of CD4
+ T cells characterized by the expression of CD25 and the nuclear transcription factor Foxp3, have been shown to play a crucial role in maintaining self-tolerance and limiting immune responses to pathogens (1) . Neonatally thymectomized mice that are devoid of Tregs develop multiorgan inflammatory disease, which is mediated by CD4 + T cells and is characterized by inflammatory infiltrates in the affected organs and autoantibody production (2) (3) (4) . A defective foxp3 gene in so-called scurfy mice results in severe autoaggression and fatal lymphoproliferative disease, identifying foxp3 as a key regulator in Treg development and function (5) (6) (7) (8) . Similarly, the human X-linked immunodeficiency syndrome IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome) is caused by mutations in the FOXP3 gene and is characterized by autoimmune disease in endocrine organs, inflammatory bowel disease, severe allergy, and fatal infection (9) .
Tregs comprise a functionally distinct cellular lineage and are continuously produced in the thymus by positive selection (10) . In the periphery, the homeostatic processes maintaining the pool size of CD4 + and CD8 + T cells have been extensively studied, but the homeostasis of Tregs is not fully understood. Clarifying the mechanisms that control maintenance of the Treg pool size is of importance for clinical applications, where Treg number is reduced after chemotherapy or lymphodepletion during organ transplantation or is dysregulated as in tumor-bearing patients or in patients suffering from autoimmune diseases (11) . Manipulation of the Treg compartment is a promising therapeutic strategy. For example, reduction of Treg number or function can promote tumor immunity, whereas Ag-specific expansion of Tregs may support transplantation tolerance and therapy of autoimmune diseases (1) . Thus, it is of importance to elucidate how Tregs differ from other T cell subsets in their homeostatic requirements and properties.
Homeostatic proliferation and survival of naive CD4 + and CD8 + T cells is largely dependent on the cytokine IL-7 (12, 13), whereas IL-15 plays an important role in the expansion and maintenance of memory CD8 + T cells (14) . In addition, it has been shown that naive T cells require contacts with self-MHC-peptide complexes as homeostatic signals, whereas most memory T cells are MHCindependent (15, 16) . Thus, upon transfer into lymphopenic hosts, T cells undergo homeostatic proliferation, which has been attributed to increased availability of MHC ligands and/or IL-7 (15, 16) . Tregs have long been thought to have very limited proliferative capacity, as they are anergic in vitro when stimulated through the TCR (17) (18) (19) and are hyporesponsive to antigenic stimuli in vivo (19) . However, in a lymphopenic environment, Tregs are capable of mounting a strong proliferative response, which is promoted by MHC class II (MHC-II) interactions (19) . Whereas IL-7 is an important growth factor for CD4 + and CD8 + T cells, IL-2 appears to play a significant role in both thymic development and *Division of Molecular Immunology, Deutsches Krebsforschungszentrum, Heidelberg; and peripheral maintenance of Tregs (20) (21) (22) . In a bone marrow chimera model, it has been demonstrated that Treg expansion depends on IL-2 mainly produced by conventional CD4 + T cells (23) . However, in a different study with cotransfer of Tregs together with conventional T cells into RAG-deficient hosts, IL-2 deficiency was unable to inhibit lymphopenia-induced homeostatic expansion of Tregs (24) . These data suggest that homeostatic requirements of Tregs may depend on the host's state of immunodeficiency and on the activation status of the surrounding cell populations.
Therefore, we investigated in the current study whether and how Tregs are capable to expand by homeostatic proliferation in an environment in which only the size of the Treg compartment is reduced, whereas the pool size and activation status of all other T cell populations remains unaltered. For this purpose, we generated novel BAC transgenic mice, designated Foxp3.LuciDTR, which permit noninvasive bioluminescence imaging of Foxp3 + Tregs via luciferase and in addition allow specific ablation of Tregs utilizing the human diphtheria toxin receptor (DTR) system. We show that following selective ablation of Tregs, the fraction of remaining Tregs underwent strong homeostatic proliferation and filled up again the Treg compartment to its original size in a thymus-independent fashion in ∼2 wk. Mechanistically, the homeostatic expansion of Tregs depended strongly on IL-2 and was supported by dendritic cells (DCs). ) mice were bred at the central animal facility of the German Cancer Research Center (Heidelberg, Germany). Foxp3EGFP mice (26) were generously provided by B. Malissen (Centre Immunologie de Marseille-Luminy, Marseille, France) via I. Prinz (Medizinische Hochschule Hannover, Hannover, Germany). All animals were held under specific pathogen-free conditions, and experiments were conducted according to governmental and institutional guidelines and regulations.
Materials and Methods

Mice and Treg depletion
For generation of Foxp3.LuciDTR BAC transgenic mice, a construct composed of the cDNAs for enhanced GFP (eGFP), the human DTR, and CBGr99 luciferase (27) was generated. Coding sequences were separated by a self-cleaving 2A peptide sequence from porcine teschovirus-1 for stoichiometric production of the three individual transgenic proteins (28) . The construct was inserted at the start codon (ATG) in the third exon of the foxp3 gene in the BAC RP23-147H5 (BACPAC Resource Center, Children's Hospital Oakland Research Institute, Oakland, CA) using Escherichia coli EL250 (29), excised using NotI, and injected into the pronuclei of fertilized B6 mouse oocytes. The resulting transgenic mouse lines were designated Foxp3.LuciDTR-3, -4, and -5. All experiments were performed using mice heterozygous for the eGFP-DTR-luciferase construct. Typing was carried out either phenotypically by flow cytometric analysis of PBLs for eGFP expression or by PCR from genomic DNA of tail biopsies using the following primers for the DTR: 59-GCCACCATGAAGCTGCTGCCG-39 and 59-TCAGTGGGAATTAGTCATGCC-39. For Treg depletion, mice were injected i.p. with 15 ng/g body weight diphtheria toxin (DT) (SigmaAldrich, St. Louis, MO), unless otherwise noted.
Bioluminescence imaging
Mice were imaged 5 min after i.p. injection of 4.5 mg D-luciferin (SynChem, Elk Grove Village, IL) using the IVIS 100 imaging system (Xenogen, Hopkinton, MA) as described (27) . Analysis was performed with LivingImage software (v2.50, Xenogen). Light output was quantified as relative light units (RLU). Where indicated, organs were removed immediately after whole body imaging and incubated in 1.5 mg/ml D-luciferin in PBS for 2 min at room temperature for imaging of isolated organs.
Flow cytometry
The following biotinylated or fluorochrome-conjugated Abs were purchased from BD Biosciences (San Jose, CA) or eBioscience (San Diego, CA): CD4 (RM4-5 or GK1.5), CD8 (53-6.7), Foxp3 (FJK-16s), CD25 (PC61 or 7D4), Ki67 (B56), CD44 (IM7), CD62L (MEL-14), CD45.1 (A20), CD45.2 (104), CD103 (M290), CD69 (H1.2F3), ICOS (7E.17G9), OX40 (OX-86), PD-1 (J43), GITR (DTA-1), CTLA-4 (UC10-4B9), CD122 (TM-b1), and CD127 (A7R34 
Statistical analysis
Results are shown as mean 6 SEM. For statistical analysis, the Student t test was applied to obtain p values as provided in the figure legends.
Results
Generation of BAC transgenic Foxp3.LuciDTR mice for in vivo Treg visualization and depletion
To study homeostasis of Foxp3 + regulatory T cells in mice, we generated a novel set of BAC transgenic mice, so-called Foxp3.LuciDTR mice, which would allow selective ablation of Tregs without causing major alterations in the conventional CD4 + and CD8 + T cell compartments. In these mice, Tregs coexpress eGFP, the DTR for depletion of Tregs, and the click-beetle luciferase CBGr99 for in vivo BLI of Tregs (Fig. 1A) . In a previous study, the CBGr99 luciferase was determined to be optimal for BLI owing to a high photon yield in the red part of the light emission spectrum (27) . To ensure expression of the three proteins as individual moieties at equimolar amounts, a technology was employed in which the coding cDNAs are separated by a self-cleaving 2A viral sequence (27, 28) . Several Foxp3-eGFP-2A-DTR-2A-luciferase founder mice were selected for further breeding on the basis of different degrees of Treg depletion. Foxp3. LuciDTR-5 mice displayed .95% Foxp3 + CD4 + T cell depletion, but depletion resulted in wasting disease, possibly due to fatal autoimmunity (data not shown). As will be discussed below, mice from lines Foxp3.LuciDTR-3 and Foxp3.LuciDTR-4 exhibited ∼75% and 90% depletion of Foxp3 + CD4 + T cells, respectively, and showed no signs of weight loss.
Upon injection of the luciferase substrate D-luciferin into Foxp3. LuciDTR mice, the measured photon emission peaked at the location of lymphoid organs such as cervical, axillary, and inguinal LNs, thymus, and peritoneal area, whereas wild-type control mice gave no signal (Fig. 1B) . The RLUs obtained were 5.21 3 10 6 RLU for Foxp3.LuciDTR-3 and 1.56 3 10 7 RLU for Foxp3.LuciDTR-4 mice, indicating a stronger expression of the BAC construct in the latter strain. After DT injection, the bioluminescence signal was strongly
The Journal of Immunologydecreased, demonstrating that most luciferase-expressing Foxp3 + Tregs were depleted (Fig. 1B) . As tissues can absorb much of the emitted photons, in particular blood-containing organs such as spleen (27) , mice were sacrificed and isolated organs imaged by BLI ( + T cells were depleted by DT in Foxp3.LuciDTR-3 mice, but ∼95% were depleted in Foxp3.LuciDTR-4 mice. In spleen, the depletion was less efficient, namely ∼65% in Foxp3.LuciDTR-3 mice and ∼90% in Foxp3.LuciDTR-4 mice (Supplemental Fig. 1b, 1c) . These findings indicated that the BACs were not expressed in all 
Homeostatic expansion of Tregs in mice with a reduced Treg compartment
Following depletion by two daily injections of DT, recovery of Tregs was assessed by noninvasive BLI. Fig. 1F and 1G show that the Treg compartment recovered with time in Foxp3.LuciDTR-3 mice. Foxp3.LuciDTR-4 mice gave similar results (data not shown). The kinetics of Treg recovery were confirmed by cytofluorometric analysis of Tregs in spleen, LNs, and blood from Foxp3.LuciDTR-3 mice. DT injection resulted in almost complete depletion of eGFP + DTR + Tregs, which comprised ∼65-75% depletion of the total Treg pool ( Fig. 2A) . The surviving eGFP -DTR -Foxp3 + Tregs and eGFP + DTR + Foxp3 + Tregs were found to recover with kinetics similar to the data obtained by BLI ( Fig. 2A) . Fig. 2A shows the frequency of Tregs and absolute Treg numbers in the spleen. The size of spleen and LNs in DT-treated Foxp3. LuciDTR-3 mice did not increase, which is in contrast to .90% Treg-depleted Foxp3.LuciDTR-4 mice, as will be shown below.
Recovery of the Treg pool may be due to homeostatic expansion of the ∼25% surviving Tregs and/or to de novo thymic output of Tregs.
Upregulation of Ki67, a marker for proliferating cells, suggested that repopulation of the Treg compartment was caused by homeostatic proliferation (Fig. 2B) Tregs could be selectively studied. Fig. 2C demonstrates that Treg number recovered in the spleen and blood with similar kinetics to that found in euthymic mice. Recovery in LNs was somewhat slower. As the recovery occurs in thymectomized animals, we conclude that the Treg compartment expanded mostly by homeostatic proliferation. As observed in euthymic mice (Fig. 2B ), Ki67 was found in a large percentage of the expanding Foxp3 + CD4 + T cells in Treg-depleted, thymectomized mice, confirming that the Tregs undergo proliferation and that homeostatic expansion of Tregs is not dependent on thymic output (Fig. 2D) . In contrast, in the same animals, only few conventional Foxp3 2 CD4 + T cells underwent proliferation, as indicated by Ki67 (Fig. 2B, 2D) .
Recovery of Treg numbers was also studied in Foxp3.LuciDTR-4 mice treated with DT. The small surviving fraction of 5-10% Foxp3 + Tregs expanded rapidly and filled up the Treg pool both in spleen and LNs within ∼2 wk (Fig. 3A) . Thus, a small residual pool of Tregs can also rapidly reconstitute the Treg compartment. However, following .90% depletion of Tregs in Foxp3.LuciDTR-4 mice, the cellularity of spleen (Fig. 3B ) and LNs (data not shown) was increased by ∼2-fold after 21 d. The total number of Tregs, CD4 + T cells (Fig.  3B ) and CD8 + T cells, B cells, macrophages, and NK cells was also increased, but the ratio of these populations was not much changed, with the exception of DCs, which were slightly decreased (Supplemental Fig. 2) . The increase in cell numbers was accompanied by activation of the conventional Foxp3
2
CD4
+ T cells, as indicated by upregulation of the activation marker CD44 and downregulation of CD62L (Fig. 3C, 3D and Supplemental Fig. 3) . In contrast, as will be shown later in the 75% depleted Foxp3.LuciDTR-3 mice, no activation of conventional CD4 + T cells was observed. To avoid a potential influence of activated conventional CD4 + T cells on the homeostatic expansion of Tregs, we focused on Foxp3.LuciDTR-3 mice for further studies.
Homeostatic proliferation of Tregs following cell transfer
The upregulation of Ki67 during Treg recovery suggests selective homeostatic proliferation of Tregs in mice with reduced Treg numbers. To study this more precisely, we investigated proliferation in a cell transfer system (Fig. 4) (Fig. 4) . Following transfer into wild-type mice, no significant proliferation of Tregs was observed, whereas transfer into T cell-deficient Rag2 2/2 mice resulted in strong proliferation of both Tregs and conventional CD4 + T cells (Fig. 4) 
Foxp3
+ CD4 + T cells was found ( Supplemental Fig. 4 ). This indicates that the repopulation of the Treg compartment is mainly due to homeostatic proliferation of Tregs and not conversion of CD4 + conventional T cells. As a control, sorted GFP + Tregs were transferred and found to proliferate in depleted Foxp3.LuciDTR-3 mice (Supplemental Fig. 5 ), as expected from results obtained following transfer of unfractionated CD4 + T cells (Fig. 5) .
Homeostatically proliferating Tregs suppress conventional T cell responses
Next, the homeostatically expanding Tregs were investigated for expression of activation markers.A number of activation markers were upregulated on homeostatically proliferating Tregs ( Fig. 5 and Supplemental Fig. 6 ), but no significant production of the cytokines IL-2, IL-4, and IFN-g by the proliferating Tregs was found (data not shown). . 7) . To see whether homeostatic expansion would affect the suppressive capacity of Tregs, proliferating Tregs were isolated from DT-treated Foxp3.LuciDTR-3 mice and compared with resting Tregs obtained from wild-type mice. Suppressive activity was measured in vitro by addition to CD4 + responder T cells stimulated by anti-CD3 Ab and splenic APCs. In several experiments, the suppressive activity of the proliferating Tregs was higher compared with steady-state Tregs (Fig. 4B) , whereas in others, no difference was observed. These results demonstrate that the Tregs maintained their suppressive capacity during proliferation and concomitant activation.
The observation that the conventional CD4 + T cell pool remained quiescent following Treg depletion (Fig. 5) indicates that in the Foxp3.LuciDTR-3 mice, the remaining 25% and homeostatically expanding Tregs were sufficient to prevent CD4 + T cell activation and autoimmunity. However, following transfer into Rag2 2/2 mice, the 25% Tregs were not able to prevent colitis and wasting disease (Fig. 6) , probably because the transferred conventional CD4 + T cells became hyperactivated by lymphopenia-induced proliferation.
Tregs require IL-2 for homeostatic proliferation IL-2 is known to be critical for maintenance and survival of Tregs (24, 33) , but homeostatic proliferation of Tregs in lymphopenic RAGdeficient mice was found to be IL-2 independent (24). Therefore, we investigated the role of IL-2 for homeostatic expansion of Tregs in Foxp3.LuciDTR-3 mice. In orientating experiments, wild-type B6 mice were treated for 5 d with anti-IL-2 Ab S4B6 (Fig. 7A ). In agreement with previous results (24, 33) , this treatment reduced the number of Foxp3 + Tregs in LNs slightly by ∼20% (Fig. 7A, right  panel) . This decrease was mainly due to a reduction of the naturally proliferating Ki67 + Tregs (Fig. 7A, left panel) . Next, depleted Foxp3. LuciDTR-3 mice were treated with anti-IL-2 Ab for 5 d. The frequency of endogenous Tregs was reduced by ∼60% by IL-2 neutralization as compared with Foxp3.LuciDTR-3 mice treated with DT only (Fig. 7B, right panel) . This difference was again mainly due to a reduction of proliferating Ki67 + Tregs (Fig. 7B, left panel) . Similar observations were made following transfer of CFSE-labeled total CD4 + T cells into Treg-depleted Foxp3.LuciDTR-3 mice. The CFSE profiles presented in Fig. 7C, 7D show that homeostatic proliferation of Tregs was strongly reduced by IL-2 starvation.
DCs promote homeostatic expansion of Tregs
Homeostatic proliferation of T cells (34, 35) and NK cells (25) was reported to depend on DCs, at least to a certain degree. Therefore, we asked whether DCs would also promote homeostatic expansion of Tregs. For this purpose, CD11c.DTR mice (designated CD11c. DOG) (25) 
Discussion
For the investigation of Treg homeostasis, a set of BAC transgenic Foxp3.LuciDTR mice was generated. The use of BACs ensures tissue-specific expression, but often BACs are not expressed in all cells of a particular tissue. Therefore, we expected to obtain Foxp3. LuciDTR mice in which not all Tregs would be deleted by application of DT so that the fate and homeostasis of the remaining Tregs could be studied. Indeed, several founder lines with different degrees of DTR expression were obtained. Foxp3.LuciDTR-5 mice displayed .95% Treg depletion, but died of wasting disease (data not shown), possibly due to autoimmunity. This is reminiscent of Foxp3.DTR knockin mice, which were described to succumb to fatal autoimmunity after Treg depletion (36) . Mouse lines Foxp3. LuciDTR-3 and Foxp3.LuciDTR-4 displayed less complete Treg depletion, namely ∼65-75% and 90-95%, respectively ( Fig. 1) and showed no signs of pathology, similar to an independent strain of BAC transgenic Foxp3.DTR mice (37) . However, the 90-95% depletion in Foxp3.LuciDTR-4 mice resulted in activation of conventional CD4 + T cells, probably due to lack of control by Tregs, whereas after 65-75% depletion in Foxp3.LuciDTR-3 mice, the conventional CD4 + T cells remained quiescent. Therefore, Foxp3. LuciDTR-3 mice were selected for further studies, as they allowed us to investigate Treg homeostasis in a situation where only the Treg compartment was reduced without concomitant major alterations in numbers and activation status of the other T cell populations.
Owing to the expression of luciferase, Tregs could be visualized in live mice by BLI, demonstrating that Tregs were mainly located in lymphoid organs (Fig. 1B, 1C) . Successful Treg depletion could be also monitored by BLI, but longitudinal studies showed that the Treg compartment was filled up again to its original size in ∼2 wk. The recovery was due to homeostatic proliferation of the remaining Tregs, as indicated by acquisition of a Ki67 + phenotype. Moreover, we observed similar return kinetics in thymectomized mice, suggesting that the de novo production of Tregs by the thymus did not contribute much to the reconstitution of the Treg compartment (Fig. 2C) . Recovery of the Treg pool appeared to be slower in LNs than in spleen or blood ( Fig. 2A, 2C) . A possible explanation is that homing receptors required for recirculation into LNs may be downregulated as a consequence of proliferation-induced activation, whereas entry into the spleen seems to be less restricted (38) . CD62L is probably not responsible for this effect, as it was generally low on Tregs (e.g., see Fig. 4A , day 0 values for CD62L).
Induction of Treg proliferation was also demonstrated in a transfer model. Following adoptive transfer of total CFSE-labeled CD4 + T cells into Treg-depleted Foxp3.LuciDTR-3 mice, the Tregs were found to expand by homeostatic proliferation, indicating that reduction of Treg number is sufficient to promote strong Treg proliferation, whereas no significant proliferation was observed after transfer into nondepleted mice (Fig. 5) . Comparable proliferation of Tregs was observed after transfer into Treg-depleted and Rag2
2/2
mice, but the underlying mechanisms appear to be different. Whereas recipients that succumbed to disease or had to be sacrificed due to health status.
The Journal of ImmunologyTreg expansion in Rag2 2/2 mice has been reported to be IL-2 independent, as shown by the use of IL-2-deficient Rag2 2/2 recipients (24), Treg expansion in Treg-depleted mice is clearly dependent on IL-2, as demonstrated in this study by Ab-mediated IL-2 neutralization (Fig. 7) . Together, the results indicate that Treg reduction is sufficient to induce proliferation of the vast majority of the remaining Tregs. It is likely that besides IL-2, additional factors are involved in Treg homeostasis. IL-2-deficient as well as IL-2Ra-and IL-2Rb-deficient mice can produce Tregs, although in decreased numbers and with functional defects, whereas common g-chain-deficient mice are completely devoid of Tregs, indicating that other g-chain cytokines are partially able to compensate for the lack of IL-2 (39, 40) . It has been reported that under lymphopenic conditions, homeostatic proliferation of conventional CD4 + T cells can cause conversion into Foxp3 + Tregs (30, 31) . This is in contrast to the results presented in this study, which failed to provide evidence for conversion ( Supplemental Fig. 4 ). Possibly this apparent discrepancy can be explained by the different experimental systems used. Whereas in the previous studies CD25 2 or Foxp3 2 conventional CD4 + T cells were transferred into lymphopenic RAG-deficient mice, where the CD4 + T cells would proliferate vigorously, we performed transfers into Treg-depleted Foxp3.LuciDTR-3 mice, in which transferred CD4 + T cells do not proliferate (Fig. 5) . The homeostatic proliferation of Tregs appears to be accompanied by cell death, as suggested by comparison of the proliferation rates and recovery of the Treg compartment. In the adoptive transfer experiments, the division rate of Tregs was at least five times per 5 d (Fig. 5) . At this rate, 10-20% of Tregs should have filled up the compartment in ∼4 to 5 d, but the actual recovery time was ∼2 wk (Figs. 2, 3) , suggesting that many proliferating Tregs die, probably due to activation-induced cell death. This is comparable to IL-2-triggered activation-induced cell death in conventional CD4 + T cells (41) . The proliferating Tregs acquired an activated phenotype and retained their suppressive activity. In fact, in several experiments, the proliferating Tregs exhibited a higher suppressive activity than Tregs isolated from a nonmanipulated mouse (Fig. 4B) .
Previous studies have shown that Ag-bearing DCs induce expansion of Tregs in vivo (42) (19) . It has been reported that DCs can transiently produce IL-2 following activation (43), but it remains to be investigated whether DC-derived IL-2 contributes to Treg expansion. Thus, DCs support lymphopenia-induced homeostatic proliferation not only for T cells and NK cells (25, 34, 35) , but also for Tregs. It should be noted that after depletion of Tregs in Foxp3.LuciDTR-3 mice, no increase in frequency and activation status of DCs was observed (Supplemental Fig. 7) , which is in contrast to Foxp3.DTR knockin mice, where the almost complete depletion of Tregs led to activation and increased numbers of DCs (36) .
The rapid homeostatic recovery of the Treg pool described in this paper is likely to be of consequence for the development of therapeutic modulation of Tregs; for example, in tumor therapy, where several strategies aim at reducing Treg numbers, or in autoimmune and transplantation situations, where an increased frequency of Tregs may be desired. In approaches where the Tregmodulating reagent is applied only for a brief time, or in situtations where Tregs become resistant to modulation, homeostatic mechanisms may adjust the Treg compartment to its original size, thereby limiting the therapeutic window. Transfer of FACS-sorted GFP + Tregs
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